MEDIPOST Co., Ltd.

078160.KQ

078160.KQMEDIPOST Co., Ltd. KR flag

KOSDAQ

8,320.00

KRW

-230.00

(-2.69%)

283.70BMarket Cap

May 12Next Earn

Upgrade to Unlock Non-US CompaniesTo view real-time data and analysis of companies outside of the United States, upgrade your account to our premium subscription.

Upgrade

MEDIPOST Co., Ltd.

078160.KQ

(KOSDAQ)

Recent

price

8,320.00

P/E

ratio

- -

div

yld

- -

ROIC.AI

Legends:

Stock price

Beta (1.0 Market)

% total return 04/18

Stock

S&P500

26.06

6.57

-65.90

22.75

-68.66

93.55

2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	TTM
854.38	1,253	2,422.32	2,483.93	2,531.01	2,474.96	2,189.2	1,600.14	2,355.89	1,238.12	2,545.52	2,695.04	2,973.2	3,423.49	3,373.38	- -	2,076.42	Revenue per Share
-66.71	133.01	300.09	103.35	60.72	-110.67	161.91	-625.25	-52.97	-55.98	-784.58	-105.07	-37.03	163.63	287	- -	-1,837.44	Basic EPS, GAAP
-490.47	-435.32	-519.88	-1,035.62	-2,136.06	-1,964.36	-900.92	-801.92	-454.01	138.95	120.29	-348.07	-360.32	-474.89	-1,066.01	- -	-1,190.95	Free Cash Flow per Basic Share
- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	Dividend per Share
674.22	785.61	1,023.78	1,001.26	1,061.49	927.76	1,087.77	-1,651.28	-1,441.95	-788.93	-2,192.15	-2,191.53	-2,157.02	-1,800.48	-927.31	- -	-2,415.08	Book Value per Share
2,288.72	1,994.72	5,524.96	4,979.74	4,663.69	4,275.31	5,880.08	5,095.03	5,367.91	3,349.55	5,883.3	6,238.18	8,428.28	9,508.69	15,200.92	- -	7,301	Tangible Book Value per Share
14	14	15	16	16	17	17	18	18	36	18	18	18	19	20	- -	34	Basic Weighted Avg Shares
11,831	18,063	35,539	40,770	41,504	41,403	37,570	28,654	42,250	44,384	45,811	48,625	54,856	64,201	68,643	70,657	70,657	Sales/Revenue/Turnover
-5.85	8.8	11.9	-2.94	-0.48	-4.29	-0.56	-53.78	-8.05	-14.85	-17.6	-4.96	-9.5	-27.13	-36.65	-68.7	-68.7	Operating Margin (%)
489	412	540	1,678	2,797	3,153	4,753	4,382	5,136	4,655	4,863	5,103	4,898	5,382	5,872	6,022	6,022	Depreciation Expense
-924	1,917	4,403	1,696	996	-1,851	2,779	-11,196	-950	-2,007	-14,120	-1,896	-683	3,069	5,840	-62,525	-62,525	Net Income, GAAP
- -	- -	- -	- -	14.42	- -	- -	- -	- -	- -	- -	717.08	260.42	67.65	- -	- -	- -	Effective Tax Rate (%)
-7.81	10.62	12.39	4.16	2.4	-4.47	7.4	-39.07	-2.25	-4.52	-30.82	-3.9	-1.25	4.78	8.51	-88.49	-88.49	Profit Margin (%)
27,483	21,116	69,155	50,935	34,367	45,040	24,649	35,123	36,767	35,734	22,703	17,603	39,684	-2,777	130,190	53,795	53,795	Working Capital
2,452	- -	521	- -	7,745	44,690	2,342	15,595	15,595	- -	354	271	1,229	1,240	7,985	7,618	7,618	LT Debt
52,012	56,397	115,041	117,227	117,423	117,338	146,482	100,712	104,439	126,804	111,959	116,915	162,193	182,578	313,657	252,601	252,601	Total Equity
- -	2.81	4.88	- -	-0.14	- -	- -	- -	- -	- -	- -	9.9	4.87	-2.7	- -	- -	- -	Return on Invested Capital (%)
- -	18.74	27.7	- -	4.04	- -	- -	- -	- -	- -	- -	6,582.57	248.26	120.65	- -	- -	- -	Return on Capital (%)
-9.53	18.56	33.42	10.79	5.88	-11.25	16.25	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	Return on Common Equity (%)

Capital Structure

•

in mil. unless spec.

Working Capital

•

in mil. unless spec.

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)	10 years	5 years	1 year
Sales/Revenue/Turnover	6.86%	9.17%	2.93%
Net Income, GAAP	-190.96%	-355.99%	-1,170.63%
Free Cash Flow	-44.1%	-23.98%	86.83%
Total Cash Common Dividend	- -	- -	- -
Total Equity	11.5%	21.61%	-19.47%

Growth Rates

•

in mil. unless spec.

Quarterly Revenue

•

in mil. unless spec.

Quarterly Earnings Per Share

•

in mil. unless spec.

Quarterly Dividends Per Share

•

in mil. unless spec.

Similar Companies: Regen BioPharma, Inc. (RGBP)
Green Cross Corporation (006280.KS)
Connect Biopharma Holdings Limited (CNTB)
Citius Pharmaceuticals, Inc. (CTXR)
Frontage Holdings Corporation (1521.HK)
Guangdong VTR Bio-Tech Co., Ltd. (300381.SZ)
Business: Medipost Co., Ltd. engages in the development and manufacture of stem cell biotechnology products. It operates through the following business divisions: Cord Blood Bank, Stem Cell Therapy, Health Functional Food, Import and Distribution of Natural Cosmetics and Healthcare Services. The Cord Blood Bank division is involved in collecting and storing stem cells from the newborn's umbilical cord. The Stem Cell Therapy division manufactures allogeneic stem cell drug products. The Health Functional Food division offers vitamins and nutritional supplements. The Import and Distribution of Natural Cosmetics division is involved in the sales and marketing of natural cosmetics imported by Pevonia Inc. The Healthcare Services division provides healthcare solutions such as bizcare, insu-care, affiliate, telehealth services and medical devices through web, mobile, and call centers. The company was founded by Yoon-Sun Yang and Won-Il Oh on June 26, 2000 and is headquartered in Seongnam, South Korea.

	Jun'24	Sep'24	Dec'24
ST Debt	3,654	3,586	3,534
LT Borrowings	6,995	6,995	6,995
LT Finance Leases	784	672	623
Preferred Equity and Hybrid Capital	- -	- -	- -
Shares Outstanding	34	34	34
Market Capitalization	177,258	193,281	392,006

	Jun'24	Sep'24	Dec'24
Total Current Assets	159,471	148,083	135,293
Accounts Receivable, Net	11,790	11,413	11,861
Cash, Cash Equivalents & STI	115,556	110,535	93,200
Inventories	14,317	15,166	16,190
Total Current Liabilities	56,771	57,006	81,498
Payables & Accruals	- -	- -	- -
ST Debt	3,654	3,586	3,534
Deferred Revenue	- -	- -	- -

2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	TTM
854.38	1,253	2,422.32	2,483.93	2,531.01	2,474.96	2,189.2	1,600.14	2,355.89	1,238.12	2,545.52	2,695.04	2,973.2	3,423.49	3,373.38	- -	2,076.42	Revenue per Share
-66.71	133.01	300.09	103.35	60.72	-110.67	161.91	-625.25	-52.97	-55.98	-784.58	-105.07	-37.03	163.63	287	- -	-1,837.44	Basic EPS, GAAP
-490.47	-435.32	-519.88	-1,035.62	-2,136.06	-1,964.36	-900.92	-801.92	-454.01	138.95	120.29	-348.07	-360.32	-474.89	-1,066.01	- -	-1,190.95	Free Cash Flow per Basic Share
- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	Dividend per Share
674.22	785.61	1,023.78	1,001.26	1,061.49	927.76	1,087.77	-1,651.28	-1,441.95	-788.93	-2,192.15	-2,191.53	-2,157.02	-1,800.48	-927.31	- -	-2,415.08	Book Value per Share
2,288.72	1,994.72	5,524.96	4,979.74	4,663.69	4,275.31	5,880.08	5,095.03	5,367.91	3,349.55	5,883.3	6,238.18	8,428.28	9,508.69	15,200.92	- -	7,301	Tangible Book Value per Share
14	14	15	16	16	17	17	18	18	36	18	18	18	19	20	- -	34	Basic Weighted Avg Shares
11,831	18,063	35,539	40,770	41,504	41,403	37,570	28,654	42,250	44,384	45,811	48,625	54,856	64,201	68,643	70,657	70,657	Sales/Revenue/Turnover
-5.85	8.8	11.9	-2.94	-0.48	-4.29	-0.56	-53.78	-8.05	-14.85	-17.6	-4.96	-9.5	-27.13	-36.65	-68.7	-68.7	Operating Margin (%)
489	412	540	1,678	2,797	3,153	4,753	4,382	5,136	4,655	4,863	5,103	4,898	5,382	5,872	6,022	6,022	Depreciation Expense
-924	1,917	4,403	1,696	996	-1,851	2,779	-11,196	-950	-2,007	-14,120	-1,896	-683	3,069	5,840	-62,525	-62,525	Net Income, GAAP
- -	- -	- -	- -	14.42	- -	- -	- -	- -	- -	- -	717.08	260.42	67.65	- -	- -	- -	Effective Tax Rate (%)
-7.81	10.62	12.39	4.16	2.4	-4.47	7.4	-39.07	-2.25	-4.52	-30.82	-3.9	-1.25	4.78	8.51	-88.49	-88.49	Profit Margin (%)
27,483	21,116	69,155	50,935	34,367	45,040	24,649	35,123	36,767	35,734	22,703	17,603	39,684	-2,777	130,190	53,795	53,795	Working Capital
2,452	- -	521	- -	7,745	44,690	2,342	15,595	15,595	- -	354	271	1,229	1,240	7,985	7,618	7,618	LT Debt
52,012	56,397	115,041	117,227	117,423	117,338	146,482	100,712	104,439	126,804	111,959	116,915	162,193	182,578	313,657	252,601	252,601	Total Equity
- -	2.81	4.88	- -	-0.14	- -	- -	- -	- -	- -	- -	9.9	4.87	-2.7	- -	- -	- -	Return on Invested Capital (%)
- -	18.74	27.7	- -	4.04	- -	- -	- -	- -	- -	- -	6,582.57	248.26	120.65	- -	- -	- -	Return on Capital (%)
-9.53	18.56	33.42	10.79	5.88	-11.25	16.25	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	Return on Common Equity (%)

Year	Q1	Q2	Q3	Q4	FY
2022	15,375	15,951	16,323	16,552	64,201
2023	17,529	16,652	17,419	17,043	68,643
2024	18,031	17,516	17,275	17,836	70,657

Year	Q1	Q2	Q3	Q4	FY
2022	-346.21	-607.16	853.47	- -	163.63
2023	-334.16	188.61	-138	- -	287
2024	- -	84	-534	- -	- -

MEDIPOST Co., Ltd.

Growth Rates

(avg. rate of change)

Growth Rates

(avg. rate of change)

Capital Structure

Working Capital

Quarterly Revenue

Year

Quarterly Dividends Per Share

Year

Quarterly Earnings Per Share

Year